Protocol Ledger

NCT03523429 · Phase II · TERMINATED

PETHEMA-BLIN-01/PET069014 (BLIN-01)

Interventional Phase II clinical trial protocol NCT03523429 sponsored by PETHEMA Foundation in Rare Genetic, Women's Health, and Other, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2018-06-30 Enrollment: 11 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT03523429
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)11 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT03523429
Protocol FieldVerified Registry Value
NCT IdentifierNCT03523429
Consolidated Lead SponsorPETHEMA Foundation
Therapeutic Condition CohortRare Genetic, Women's Health, and Other
Clinical Trial PhasePhase II
Overall Recruitment StatusTERMINATED
Registered Enrollment11 participants (ACTUAL)
Registered Start Date2018-06-30
WhyStopped ClassificationInsufficient / Slow Accrual

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT03523429
Hospital Research SiteLocationSite Profile
Hospital Germans Trias i PujolBadalona, SpainOpen Hospital Dossier ->
Hospital Clínic de BarcelonaBarcelona, SpainOpen Hospital Dossier ->
Hospital de La Santa Creu I Sant PauBarcelona, SpainOpen Hospital Dossier ->
Hospital Vall d' HebronBarcelona, SpainOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Rare Genetic, Women's Health, and Other Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI